common.study.topics.clinical

Pharmacogenomic Testing in Antidepressant Drug Therapy

common.study.values.description

Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy

A randomized controlled trial comparing pharmacogenomic guided versus standard pharmacist care to optimize antidepressant drug therapy. This study evaluates the effectiveness of pharmacists utilizing pharmacogenomic testing in the community pharmacy setting to help patients find the most appropriate drug therapy option(s) and minimize the risk of side effects in collaboration with prescribing physicians.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Pharmacogenomic Testing

pharmacogenomic drug response test provides personalized insights on a patient's predicted response to medications based on metabolism

Pharmacist Standard of Care

Pharmacist providing standard of care as per usual practice

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Randomized Controlled Trial of Pharmacogenomic Guided Versus Standard Pharmacist Care to Optimize Antidepressant Drug Therapy in a Community Pharmacy Setting

common.study.values.clinical-trial-id

NCT03591224

participant.views.study.view.id

egJJGd